Details for New Drug Application (NDA): 021262
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in ALPHAGAN P is brimonidine tartrate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the brimonidine tartrate profile page.
Summary for 021262
Tradename: | ALPHAGAN P |
Applicant: | Allergan |
Ingredient: | brimonidine tartrate |
Patents: | 5 |
Pharmacology for NDA: 021262
Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for 021262
Suppliers and Packaging for NDA: 021262
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262 | NDA | Allergan, Inc. | 0023-9177 | 0023-9177-05 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-05) / 5 mL in 1 BOTTLE, DROPPER |
ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262 | NDA | Allergan, Inc. | 0023-9177 | 0023-9177-10 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9177-10) / 10 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.15% | ||||
Approval Date: | Mar 16, 2001 | TE: | AT | RLD: | Yes | ||||
Patent: | See Plans and Pricing | Patent Expiration: | Jan 10, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
Patent: | See Plans and Pricing | Patent Expiration: | Jan 18, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
Patent: | See Plans and Pricing | Patent Expiration: | Jan 28, 2022 | Product Flag? | Substance Flag? | Delist Request? |
Expired US Patents for NDA 021262
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | See Plans and Pricing | See Plans and Pricing |
Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | See Plans and Pricing | See Plans and Pricing |
Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | See Plans and Pricing | See Plans and Pricing |
Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | See Plans and Pricing | See Plans and Pricing |
Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription